The Institute of Immunology has begun negotiations with a Canadian company on the import of raw material for the production of hemp-based products, and if all conditions stipulated by the Health Ministry's rules governing Indian hemp use for medical purposes are met, those products might come to the shelves of Croatian pharmacies in late February or in early March, the Institute's director Nevenka Kovac said on Wednesday.
The negotiations are being held on the price, delivery and other important aspects of possible future cooperation, said Kovac, expressing hope that an agreement would be reached.
This is a respectable producer with registered production in Canada. In order to conclude the agreement, it must meet all parameters from the Croatian rules on the models and necessary concentration of THC active substance for manufacturing products, she added.
The rules, adopted in October 2015, set a legal framework for the import of hemp-based medicines into Croatia, requiring that medicines containing tetrahydrocannabinol (THC), dronabinol and nabilone may only be dispensed by pharmacies on prescription.
Only patients suffering from multiple sclerosis, cancer, epilepsy and AIDS are eligible to use such medicines.